术后糖皮质激素对A型主动脉夹层器官功能障碍的随机对照试验
结果显示糖皮质激素组术后第4天SOFA评分较基线的降幅更大,炎症指标更低,需持续肾脏替代治疗的患者更少。
要点
- 术后糖皮质激素可改善A型主动脉夹层患者早期器官功能障碍恢复。
- 糖皮质激素组术后第4天SOFA评分降幅更大,炎症指标更低。
- 糖皮质激素组需持续肾脏替代治疗的患者比例更低。
核心结论
- 术后糖皮质激素可显著减轻A型主动脉夹层患者术后炎症并改善早期器官功能障碍恢复。
研究设计与样本
- 糖皮质激素组静脉给予甲泼尼龙3天。
主要发现
- 主要结局SOFA评分降幅:对照组3.16±2.52,糖皮质激素组4.36±2.82,绝对差异1.20(95%CI 0.52-1.93),P=0.001。
- 术后第4天高敏C反应蛋白中位数:糖皮质激素组91.0 mg/l,对照组182.0 mg/l,绝对差异-91(95%CI -122至-57),P=0.009。
- 需持续肾脏替代治疗比例:糖皮质激素组8.5%,对照组19.8%,绝对差异-10.4(95%CI -19.1至-1.3),P=0.03。
临床怎么用
- 可考虑在A型主动脉夹层术后早期使用糖皮质激素以减轻炎症和促进器官功能恢复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aims to evaluate the organ-protective efficacy of postoperative glucocorticoid in patients with type A aortic dissection. METHODS: Postoperative type A aortic dissection patients were randomly allocated to receive either postoperative glucocorticoid or standard-of-care treatment. Intravenous methylprednisolone was administered for 3 days. The primary outcome was the reduction of Sequential Organ Failure Assessment score on postoperative day 4 compared to baseline (on postoperative day 1 before methylprednisolone administration). RESULTS: Two hundred twelve patients were included in the intention-to-treat analysis. The primary outcome was significantly different between groups: 3.16 ± 2.52 in the control group versus 4.36 ± 2.82 in the glucocorticoid group (absolute difference 1.20 [95% CI 0.52-1.93], P = 0.001). The glucocorticoid group showed markedly lower median high-sensitivity C-reactive protein levels compared to the control group (91.0 mg/l vs 182.0 mg/l; absolute difference: -91 (95% CI -122 to -57), P = 0.009) on postoperative day 4. Fewer patients in the glucocorticoid group required continuous renal replacement therapy (8.5% vs 19.8% in the control group; absolute difference: -10.4 [95% CI -19.1 to -1.3], P = 0.03). CONCLUSIONS: This trial demonstrates that postoperative glucocorticoid in patients with type A aortic dissection significantly reduces postoperative inflammation and improves recovery of early organ dysfunction. These findings advocate for the implementation of glucocorticoid in the early phase after surgery for enhanced organ protection.
引用
- Luo MH, Luo JC, Xu X, et al. Effects of postoperative glucocorticoids on mitigation of organ dysfunction in patients with type A aortic dissection: a randomized controlled trial. Eur J Cardiothorac Surg. 2024. PMID: 39657253. doi:10.1093/ejcts/ezae441
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。